Cointime

Century Therapeutics, Inc

company

About

Century Therapeutics is a leading cell therapy company developing induced pluripotent stem

  • 101 - 250

Highlights

Total Funding Amount
$410M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$250M
Industries
Biotechnology,Health Care,Health Diagnostics,Therapeutics
Founded date
Jan 1, 2018
Number Of Employee
101 - 250
Operating Status
Active

Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer. The company's genetically-engineered, iPSC-derived immune effector cell products are designed to specifically target hematologic and solid cancers by harnessing the power of adult stem cells, providing patients with an unparalleled opportunity to advance the course of cancer care.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$410M
Century Therapeutics, Inc has raised a total of $410M in funding over 2 rounds. Their latest funding was raised on Mar 3, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 3, 2021 Series C $160M 1 — — Detail
Jul 1, 2019 Series A $250M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Century Therapeutics, Inc is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures — Series C
Cointime
เนื้อหา
บริษัท